This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prince, H. E.
Right arrow Articles by Hogrefe, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prince, H. E.
Right arrow Articles by Hogrefe, W. R.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, January 2003, p. 177-179, Vol. 10, No. 1
1071-412X/03/$08.00+0     DOI: 10.1128/CDLI.10.1.177-179.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Performance Characteristics of an In-House Assay System Used To Detect West Nile Virus (WNV)-Specific Immunoglobulin M during the 2001 WNV Season in the United States

Harry E. Prince* and Wayne R. Hogrefe

Focus Technologies, Cypress, California

Received 23 August 2002/ Returned for modification 26 September 2002/ Accepted 4 October 2002

During the 2001 U. S. West Nile virus (WNV) season, 163 specimens were reactive in an in-house WNV-specific immunoglobulin M (IgM) screening enzyme-linked immunosorbent assay (ELISA) and were referred to either the Centers for Disease Control and Prevention or the appropriate state public health laboratory (CDC/SPHL) for additional testing. CDC/SPHL supplied results for 124 specimens that could be further evaluated in-house: 70 specimens were nonreactive in the CDC/SPHL WNV-specific IgM screening assay, and 54 specimens were reactive. These specimens were used to evaluate a modified in-house WNV-specific IgM ELISA that incorporated background subtraction to identify nonspecific reactivity and thus improve assay specificity. Of the 70 CDC/SPHL nonreactive samples, 49 (70%) were nonreactive in the modified ELISA; of the 54 CDC/SPHL reactive samples, 51 (94%) were reactive in the modified ELISA. Confirmatory studies performed by CDC/SPHL indicated that 38 CDC/SPHL screen-reactive specimens represented true WNV infection; all 38 specimens were reactive in the modified in-house WNV-specific IgM ELISA. These findings demonstrate that an in-house ELISA system for WNV-specific IgM effectively identifies patients with WNV infection.

* Corresponding author. Mailing address: Focus Technologies, 5785 Corporate Ave., Cypress, CA 90630. Phone: (714) 503-2047. Fax: (714) 484-1296. E-mail: hprince{at}focusanswers.com.

Clinical and Diagnostic Laboratory Immunology, January 2003, p. 177-179, Vol. 10, No. 1
1071-412X/03/$08.00+0     DOI: 10.1128/CDLI.10.1.177-179.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Tilley, P. A. G., Walle, R., Chow, A., Jayaraman, G. C., Fonseca, K., Drebot, M. A., Preiksaitis, J., Fox, J. (2005). Clinical Utility of Commercial Enzyme Immunoassays during the Inaugural Season of West Nile Virus Activity, Alberta, Canada. J. Clin. Microbiol. 43: 4691-4695 [Abstract] [Full Text]  
  • Hogrefe, W. R., Moore, R., Lape-Nixon, M., Wagner, M., Prince, H. E. (2004). Performance of Immunoglobulin G (IgG) and IgM Enzyme-Linked Immunosorbent Assays Using a West Nile Virus Recombinant Antigen (preM/E) for Detection of West Nile Virus- and Other Flavivirus-Specific Antibodies. J. Clin. Microbiol. 42: 4641-4648 [Abstract] [Full Text]  
  • Beasley, D. W. C., Holbrook, M. R., Travassos da Rosa, A. P. A., Coffey, L., Carrara, A.-S., Phillippi-Falkenstein, K., Bohm, R. P. Jr., Ratterree, M. S., Lillibridge, K. M., Ludwig, G. V., Estrada-Franco, J., Weaver, S. C., Tesh, R. B., Shope, R. E., Barrett, A. D. T. (2004). Use of a Recombinant Envelope Protein Subunit Antigen for Specific Serological Diagnosis of West Nile Virus Infection. J. Clin. Microbiol. 42: 2759-2765 [Abstract] [Full Text]  
  • Malan, A. K., Martins, T. B., Hill, H. R., Litwin, C. M. (2004). Evaluations of Commercial West Nile Virus Immunoglobulin G (IgG) and IgM Enzyme Immunoassays Show the Value of Continuous Validation. J. Clin. Microbiol. 42: 727-733 [Abstract] [Full Text]  
  • Prince, H. E., Lape'-Nixon, M., Moore, R. J., Hogrefe, W. R. (2004). Utility of the Focus Technologies West Nile Virus Immunoglobulin M Capture Enzyme-Linked Immunosorbent Assay for Testing Cerebrospinal Fluid. J. Clin. Microbiol. 42: 12-15 [Abstract] [Full Text]  
  • Prince, H. E., Hogrefe, W. R. (2003). Detection of West Nile Virus (WNV)-Specific Immunoglobulin M in a Reference Laboratory Setting during the 2002 WNV Season in the United States. CVI 10: 764-768 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»